Patrick Dougherty

Advising COO at Nobias Therapeutics

Patrick Dougherty's work experience includes:

- Founder/Owner at Beech Street Advisors since September 2021 (current role).

- Member of the Health Investment Review Committee at Ben Franklin Technology Partners of Southeastern Pennsylvania since 2015.

- Acting COO and Consultant at Nobias Therapeutics, with roles starting in October 2022 and November 2021 respectively (current roles).

- SVP, Strategy, Planning & Operations at WindMIL Therapeutics from January 2020 to June 2021.

- VP Planning & Operations at WindMIL Therapeutics from March 2019 to January 2020.

- VP Operations at WindMIL Therapeutics from July 2018 to March 2019.

- Director of Strategy / Chief of Staff, R&D Pipeline at GSK from March 2016 to July 2018.

- Business Lead, R&D Places Programme at GSK from March 2013 to March 2016.

- Head, R&D Programme Management Office at GSK from February 2012 to December 2013.

- BD Centre of Excellence Director of Strategy Implementation at GSK from November 2010 to January 2012.

- R&D Strategy Office Director at GSK from November 2009 to December 2010.

- Engagement Manager and Consultant at L.E.K. Consulting, with roles starting in April 2008 and September 2006 respectively.

- Intern, Dirección de Investigación y Desarrollo at Laboratorios Bago in July 2006-August 2006.

- Intern, Business Development at Endo Pharmaceuticals in June 2005-August 2005.

- Associate Director, Life Sciences Licensing at CTT, University of Pennsylvania from November 2001 to May 2004.

Patrick Dougherty began their education at Bishop Hoban High School, where they completed their secondary education from 1992 to 1996. Patrick then attended Villanova University from 1996 to 2000, earning a Bachelor of Science (B.S.) degree in Chemistry. Following this, they pursued further studies at Alliance Manchester Business School from 2000 to 2001, obtaining a Master of Science (MSc) degree in Technology Management. Finally, Patrick attended The Wharton School from 2004 to 2006, where they obtained an M.B.A. degree with a focus on Finance and Health Care Management.

Links

Previous companies

WindMIL Therapeutics logo
University of Pennsylvania logo

Timeline

  • Advising COO

    October, 2022 - present

  • Consultant

    November, 2021